Published in Exp Biol Med (Maywood) on May 01, 2016
Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett (2006) 10.12
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Immunological properties of engineered nanomaterials. Nat Nanotechnol (2007) 5.59
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem (2004) 3.52
Pulmonary and systemic immune response to inhaled multiwalled carbon nanotubes. Toxicol Sci (2007) 3.52
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis. Nat Biotechnol (2012) 3.11
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev (2009) 3.08
Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol (2008) 2.97
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol Pharm (2008) 2.94
Gold nanoparticles in biomedical applications: recent advances and perspectives. Chem Soc Rev (2011) 2.54
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun (Camb) (2007) 2.42
Nanotechnology safety concerns revisited. Toxicol Sci (2007) 2.41
Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A (1997) 2.05
Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol (2010) 2.00
Topical delivery of silver nanoparticles promotes wound healing. ChemMedChem (2007) 1.91
Anti-inflammatory properties of cerium oxide nanoparticles. Small (2009) 1.86
[60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett (2005) 1.83
Nanoparticles and the immune system. Endocrinology (2009) 1.79
A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci Transl Med (2011) 1.69
Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small (2009) 1.69
Applications of nanotechnology for immunology. Nat Rev Immunol (2013) 1.65
Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. Am J Physiol Regul Integr Comp Physiol (2004) 1.63
A self-assembling peptide acting as an immune adjuvant. Proc Natl Acad Sci U S A (2009) 1.62
Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano (2012) 1.62
Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnology (2014) 1.59
Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc (2012) 1.57
Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. Nat Nanotechnol (2009) 1.57
Gold nanoparticles: a revival in precious metal administration to patients. Nano Lett (2011) 1.47
Fullerene nanomaterials inhibit the allergic response. J Immunol (2007) 1.40
The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction. Nanoscale Res Lett (2009) 1.40
Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum (2003) 1.39
Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol Lett (2010) 1.38
Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine (2010) 1.34
Challenges in development of nanoparticle-based therapeutics. AAPS J (2012) 1.28
Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nat Biotechnol (2004) 1.26
The effects of nano-silver on the proliferation and cytokine expression by peripheral blood mononuclear cells. Int Immunopharmacol (2007) 1.24
The role of nanotoxicology in realizing the 'helping without harm' paradigm of nanomedicine: lessons from studies of pulmonary effects of single-walled carbon nanotubes. J Intern Med (2010) 1.19
Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol (2005) 1.14
Redox-active radical scavenging nanomaterials. Chem Soc Rev (2010) 1.12
Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano (2011) 1.11
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proc Natl Acad Sci U S A (2014) 1.10
Antifungal activity of ZnO nanoparticles--the role of ROS mediated cell injury. Nanotechnology (2011) 1.07
Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer. PLoS One (2012) 1.04
Overcoming immunological barriers in regenerative medicine. Nat Biotechnol (2014) 1.02
Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLoS One (2013) 1.02
Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo. Adv Mater (2012) 1.01
A meta-analysis of carbon nanotube pulmonary toxicity studies--how physical dimensions and impurities affect the toxicity of carbon nanotubes. Risk Anal (2013) 0.99
A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice. Int J Nanomedicine (2011) 0.99
Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology (2011) 0.98
SWCNT suppress inflammatory mediator responses in human lung epithelium in vitro. Toxicol Appl Pharmacol (2008) 0.98
Safe clinical use of carbon nanotubes as innovative biomaterials. Chem Rev (2014) 0.98
Gold Nanoparticles: Recent Advances in the Biomedical Applications. Cell Biochem Biophys (2015) 0.96
Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers. Biomacromolecules (2009) 0.94
Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta Biomater (2011) 0.94
Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response. ACS Nano (2015) 0.93
Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses. PLoS Comput Biol (2011) 0.93
In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice. PLoS One (2013) 0.93
Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating. ACS Nano (2013) 0.93
Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig Dis Sci (2007) 0.92
Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses. Small (2012) 0.92
Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain. ACS Nano (2013) 0.91
Effects of subtoxic concentrations of TiO2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol Appl Pharmacol (2012) 0.90
Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol (2014) 0.90
Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis. Int J Nanomedicine (2009) 0.90
Increased bone marrow toxicity of doxorubicin bound to nanoparticles. Eur J Cancer (1994) 0.88
An increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticles. J Immunotoxicol (2011) 0.87
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines. Toxicology (2009) 0.86
Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells. Part Fibre Toxicol (2013) 0.85
Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers. EMBO Mol Med (2012) 0.85
Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake. Biomaterials (2015) 0.84
Independent cytotoxic and inflammatory responses to zinc oxide nanoparticles in human monocytes and macrophages. Nanotoxicology (2011) 0.84
Pharmacogenetics and immunosuppressive drugs in solid organ transplantation. Nat Rev Nephrol (2014) 0.84
Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release (2015) 0.83
Immunotoxicity of zinc oxide nanoparticles with different size and electrostatic charge. Int J Nanomedicine (2014) 0.83
Opposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60). Biomaterials (2009) 0.83
Immunosuppressive drug therapy. Cold Spring Harb Perspect Med (2013) 0.83
Functionalized polystyrene nanoparticles trigger human dendritic cell maturation resulting in enhanced CD4+ T cell activation. Macromol Biosci (2012) 0.82
Nanomedicine in autoimmunity. Immunol Lett (2014) 0.82
Intracellular accumulation and immunological properties of fluorescent gold nanoclusters in human dendritic cells. Biomaterials (2014) 0.81
Localized immunosuppression in the cardiac allograft induced by a new liposome-mediated IL-10 gene therapy. J Heart Lung Transplant (2002) 0.81
Inert 50-nm polystyrene nanoparticles that modify pulmonary dendritic cell function and inhibit allergic airway inflammation. J Immunol (2011) 0.81
Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments. Nanomedicine (Lond) (2015) 0.80
Nanotoxicology: How do nanotubes suppress T cells? Nat Nanotechnol (2009) 0.80
Modulation of inflammatory signaling and cytokine release from microglia by celastrol incorporated into dendrimer nanocarriers. Nanomedicine (Lond) (2012) 0.80
Investigating the immunomodulatory nature of zinc oxide nanoparticles at sub-cytotoxic levels in vitro and after intranasal instillation in vivo. J Nanobiotechnology (2015) 0.80
Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells. Langmuir (2015) 0.80
Iron oxide nanoparticles suppressed T helper 1 cell-mediated immunity in a murine model of delayed-type hypersensitivity. Int J Nanomedicine (2012) 0.79
Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time. Int J Pharm (2013) 0.79
Intracellular Uptake of Curcumin-Loaded Solid Lipid Nanoparticles Exhibit Anti-Inflammatory Activities Superior to Those of Curcumin Through the NF-κB Signaling Pathway. J Biomed Nanotechnol (2015) 0.78
Effect of ultrafine zinc oxide (ZnO) nanoparticles on induction of oral tolerance in mice. J Immunotoxicol (2010) 0.78
Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. Biomaterials (2015) 0.78
Dendrimers to treat rheumatoid arthritis. ACS Nano (2011) 0.78
Toll-like receptor-mediated adjuvanticity and immunomodulation in dendritic cells: Implications for peptide vaccines. Hum Vaccin (2011) 0.78
Engineered metal based nanoparticles and innate immunity. Clin Mol Allergy (2015) 0.78
Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases. AAPS J (2015) 0.77
Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine (2014) 0.77
The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. Transplantation (1995) 0.77
An investigation into the interactions of gold nanoparticles and anti-arthritic drugs with macrophages, and their reactivity towards thioredoxin reductase. J Inorg Biochem (2014) 0.76
Partial mitigation of gold nanoparticle interactions with human lymphocytes by surface functionalization with a 'mixed matrix'. Nanomedicine (Lond) (2014) 0.76